«But we have to be honest and say that, based on all the evidence, including data
presented by the drug companies themselves, our experts have concluded that these drugs do not make enough of a difference for us to recommend their use for treating all stages of Alzheimer's disease.
ImmuPharma PLC (LON: IMM), specialist
drug discovery and development
company, announced that its chairman Tim McCarthy will be
presenting at an investor evening hosted
by Turner Pope Investments, which acted as agent in the firm's recent # 10mln fundraise.